Churchill Capital Corp VII (NYSE: CVII) Stock Competitors & Peer Comparison

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CCIV trades at $24.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CCIV's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to CCIV's ROE of -13.92%. Regarding short-term risk, CVII is less volatile compared to CCIV. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CCIV's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while PSACU trades at $17.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas PSACU's P/E ratio is -108.79. In terms of profitability, CVII's ROE is +0.02%, compared to PSACU's ROE of -35.44%. Regarding short-term risk, CVII is less volatile compared to PSACU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check PSACU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while RTPY trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas RTPY's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to RTPY's ROE of -0.43%. Regarding short-term risk, CVII is less volatile compared to RTPY. This indicates lower risk in terms of short-term price fluctuations for CVII.Check RTPY's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while LVRAW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas LVRAW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to LVRAW's ROE of N/A. Regarding short-term risk, CVII is less volatile compared to LVRAW. This indicates lower risk in terms of short-term price fluctuations for CVII.Check LVRAW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CMLFU has a market cap of 10.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CMLFU trades at $13.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, CVII's ROE is +0.02%, compared to CMLFU's ROE of -0.39%. Regarding short-term risk, CVII is less volatile compared to CMLFU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CMLFU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while PSAC trades at $13.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas PSAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to PSAC's ROE of -35.44%. Regarding short-term risk, CVII is less volatile compared to PSAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check PSAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GRSVU trades at $11.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GRSVU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, CVII is more volatile compared to GRSVU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check GRSVU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while APSG trades at $7.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas APSG's P/E ratio is 36.95. In terms of profitability, CVII's ROE is +0.02%, compared to APSG's ROE of +0.03%. Regarding short-term risk, CVII is less volatile compared to APSG. This indicates lower risk in terms of short-term price fluctuations for CVII.Check APSG's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while RTP trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas RTP's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to RTP's ROE of -0.58%. Regarding short-term risk, CVII is less volatile compared to RTP. This indicates lower risk in terms of short-term price fluctuations for CVII.Check RTP's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DGNR trades at $9.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DGNR's P/E ratio is -308.67. In terms of profitability, CVII's ROE is +0.02%, compared to DGNR's ROE of +0.02%. Regarding short-term risk, CVII is less volatile compared to DGNR. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DGNR's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while VTIQ trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, CVII's ROE is +0.02%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, CVII is more volatile compared to VTIQ. This indicates higher risk in terms of short-term price fluctuations for CVII.Check VTIQ's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while VTIQU trades at $10.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, CVII's ROE is +0.02%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, CVII is more volatile compared to VTIQU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check VTIQU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while VACQ trades at $11.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas VACQ's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to VACQ's ROE of -0.08%. Regarding short-term risk, CVII is less volatile compared to VACQ. This indicates lower risk in terms of short-term price fluctuations for CVII.Check VACQ's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SVFC trades at $9.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SVFC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SVFC's ROE of +0.05%. Regarding short-term risk, CVII is less volatile compared to SVFC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SVFC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while VGAC trades at $10.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas VGAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to VGAC's ROE of -1.21%. Regarding short-term risk, CVII is less volatile compared to VGAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check VGAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CMLT has a market cap of 4.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CMLT trades at $8.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CMLT's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to CMLT's ROE of N/A. Regarding short-term risk, CVII is less volatile compared to CMLT. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CMLT's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GHVI trades at $14.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GHVI's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to GHVI's ROE of -1.28%. Regarding short-term risk, CVII is less volatile compared to GHVI. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GHVI's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while KVSB trades at $11.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas KVSB's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to KVSB's ROE of -0.07%. Regarding short-term risk, CVII is less volatile compared to KVSB. This indicates lower risk in terms of short-term price fluctuations for CVII.Check KVSB's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FTOCU trades at $11.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FTOCU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FTOCU's ROE of +0.07%. Regarding short-term risk, CVII is less volatile compared to FTOCU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FTOCU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while THCBU trades at $12.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas THCBU's P/E ratio is -101.87. In terms of profitability, CVII's ROE is +0.02%, compared to THCBU's ROE of +0.01%. Regarding short-term risk, CVII is less volatile compared to THCBU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check THCBU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CLII has a market cap of 3.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CLII trades at $14.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CLII's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to CLII's ROE of -0.31%. Regarding short-term risk, CVII is less volatile compared to CLII. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CLII's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GRNV trades at $12.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GRNV's P/E ratio is -59.68. In terms of profitability, CVII's ROE is +0.02%, compared to GRNV's ROE of +0.05%. Regarding short-term risk, CVII is less volatile compared to GRNV. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GRNV's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FRX trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FRX's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FRX's ROE of +0.39%. Regarding short-term risk, CVII is less volatile compared to FRX. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FRX's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HOLUU trades at $13.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HOLUU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, CVII is less volatile compared to HOLUU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check HOLUU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SSPK trades at $18.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SSPK's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SSPK's ROE of +0.04%. Regarding short-term risk, CVII is less volatile compared to SSPK. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SSPK's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FCACU trades at $9.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FCACU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, CVII is less volatile compared to FCACU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FCACU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CFVI trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CFVI's P/E ratio is -18.55. In terms of profitability, CVII's ROE is +0.02%, compared to CFVI's ROE of -0.47%. Regarding short-term risk, CVII is less volatile compared to CFVI. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CFVI's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HOL trades at $12.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HOL's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to HOL's ROE of -0.13%. Regarding short-term risk, CVII is less volatile compared to HOL. This indicates lower risk in terms of short-term price fluctuations for CVII.Check HOL's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CCXIW has a market cap of 3.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CCXIW trades at $7.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CCXIW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to CCXIW's ROE of N/A. Regarding short-term risk, CVII is less volatile compared to CCXIW. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CCXIW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while THCB trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas THCB's P/E ratio is -81.30. In terms of profitability, CVII's ROE is +0.02%, compared to THCB's ROE of +0.01%. Regarding short-term risk, CVII is less volatile compared to THCB. This indicates lower risk in terms of short-term price fluctuations for CVII.Check THCB's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SOAC trades at $10.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SOAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SOAC's ROE of +3.51%. Regarding short-term risk, CVII is less volatile compared to SOAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SOAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DCRBU trades at $11.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, CVII's ROE is +0.02%, compared to DCRBU's ROE of -0.84%. Regarding short-term risk, CVII is less volatile compared to DCRBU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DCRBU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while IVAN trades at $7.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas IVAN's P/E ratio is -698.18. In terms of profitability, CVII's ROE is +0.02%, compared to IVAN's ROE of -0.33%. Regarding short-term risk, CVII is less volatile compared to IVAN. This indicates lower risk in terms of short-term price fluctuations for CVII.Check IVAN's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GWAC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GWAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to GWAC's ROE of -0.59%. Regarding short-term risk, CVII is less volatile compared to GWAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GWAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while LCYAU trades at $13.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas LCYAU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to LCYAU's ROE of +0.04%. Regarding short-term risk, CVII is more volatile compared to LCYAU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check LCYAU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FWAA trades at $12.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FWAA's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FWAA's ROE of -0.09%. Regarding short-term risk, CVII is less volatile compared to FWAA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FWAA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GSAH trades at $10.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GSAH's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to GSAH's ROE of +0.42%. Regarding short-term risk, CVII is less volatile compared to GSAH. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GSAH's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while LCY trades at $12.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas LCY's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to LCY's ROE of +0.04%. Regarding short-term risk, CVII is less volatile compared to LCY. This indicates lower risk in terms of short-term price fluctuations for CVII.Check LCY's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FORE trades at $9.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FORE's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FORE's ROE of +3.90%. Regarding short-term risk, CVII is less volatile compared to FORE. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FORE's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while RAAC trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas RAAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to RAAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check RAAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SPNV trades at $8.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SPNV's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SPNV's ROE of -0.99%. Regarding short-term risk, CVII is less volatile compared to SPNV. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SPNV's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DNAC trades at $9.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DNAC's P/E ratio is -37.72. In terms of profitability, CVII's ROE is +0.02%, compared to DNAC's ROE of -0.36%. Regarding short-term risk, CVII is less volatile compared to DNAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DNAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FAII trades at $10.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FAII's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FAII's ROE of -0.32%. Regarding short-term risk, CVII is less volatile compared to FAII. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FAII's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DMYI trades at $10.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DMYI's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to DMYI's ROE of -0.16%. Regarding short-term risk, CVII is less volatile compared to DMYI. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DMYI's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while LOKB trades at $13.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas LOKB's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to LOKB's ROE of -0.62%. Regarding short-term risk, CVII is less volatile compared to LOKB. This indicates lower risk in terms of short-term price fluctuations for CVII.Check LOKB's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, STPC has a market cap of 2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while STPC trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas STPC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to STPC's ROE of -0.29%. Regarding short-term risk, CVII is less volatile compared to STPC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check STPC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while MUDS trades at $10.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas MUDS's P/E ratio is 3.39. In terms of profitability, CVII's ROE is +0.02%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, CVII is more volatile compared to MUDS. This indicates higher risk in terms of short-term price fluctuations for CVII.Check MUDS's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while MUDSU trades at $10.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, CVII's ROE is +0.02%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, CVII is more volatile compared to MUDSU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check MUDSU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, TINV has a market cap of 2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while TINV trades at $11.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas TINV's P/E ratio is 30.61. In terms of profitability, CVII's ROE is +0.02%, compared to TINV's ROE of +3.57%. Regarding short-term risk, CVII is less volatile compared to TINV. This indicates lower risk in terms of short-term price fluctuations for CVII.Check TINV's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, APXT has a market cap of 1.9B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while APXT trades at $10.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas APXT's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to APXT's ROE of +0.16%. Regarding short-term risk, CVII is more volatile compared to APXT. This indicates higher risk in terms of short-term price fluctuations for CVII.Check APXT's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, APXTU has a market cap of 1.9B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while APXTU trades at $10.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas APXTU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to APXTU's ROE of +0.16%. Regarding short-term risk, CVII is more volatile compared to APXTU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check APXTU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DWAC trades at $49.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DWAC's P/E ratio is -73.46. In terms of profitability, CVII's ROE is +0.02%, compared to DWAC's ROE of -0.84%. Regarding short-term risk, CVII is less volatile compared to DWAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DWAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DWACU trades at $61.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DWACU's P/E ratio is -451.10. In terms of profitability, CVII's ROE is +0.02%, compared to DWACU's ROE of -0.84%. Regarding short-term risk, CVII is less volatile compared to DWACU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DWACU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while ATHN trades at $9.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas ATHN's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to ATHN's ROE of +2.24%. Regarding short-term risk, CVII is less volatile compared to ATHN. This indicates lower risk in terms of short-term price fluctuations for CVII.Check ATHN's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GMII trades at $8.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GMII's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to GMII's ROE of +0.21%. Regarding short-term risk, CVII is less volatile compared to GMII. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GMII's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while MOTV trades at $10.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas MOTV's P/E ratio is 55.86. In terms of profitability, CVII's ROE is +0.02%, compared to MOTV's ROE of -0.23%. Regarding short-term risk, CVII is less volatile compared to MOTV. This indicates lower risk in terms of short-term price fluctuations for CVII.Check MOTV's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CBAH trades at $10.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CBAH's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to CBAH's ROE of +0.04%. Regarding short-term risk, CVII is less volatile compared to CBAH. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CBAH's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GXGXU trades at $11.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, CVII's ROE is +0.02%, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, CVII is less volatile compared to GXGXU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GXGXU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, APXTW has a market cap of 1.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while APXTW trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas APXTW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to APXTW's ROE of +0.16%. Regarding short-term risk, CVII is more volatile compared to APXTW. This indicates higher risk in terms of short-term price fluctuations for CVII.Check APXTW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while AONE trades at $8.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas AONE's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to AONE's ROE of -17.11%. Regarding short-term risk, CVII is less volatile compared to AONE. This indicates lower risk in terms of short-term price fluctuations for CVII.Check AONE's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SNPR trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SNPR's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to SNPR. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SNPR's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SPFR trades at $8.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SPFR's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SPFR's ROE of -4.57%. Regarding short-term risk, CVII is less volatile compared to SPFR. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SPFR's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DEH trades at $11.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DEH's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to DEH's ROE of -3.33%. Regarding short-term risk, CVII is less volatile compared to DEH. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DEH's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while ROT trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas ROT's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to ROT's ROE of -0.45%. Regarding short-term risk, CVII is less volatile compared to ROT. This indicates lower risk in terms of short-term price fluctuations for CVII.Check ROT's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while NGAC trades at $8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas NGAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to NGAC's ROE of -0.87%. Regarding short-term risk, CVII is less volatile compared to NGAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check NGAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, GXGX has a market cap of 1.5B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while GXGX trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas GXGX's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to GXGX's ROE of +4.12%. Regarding short-term risk, CVII is less volatile compared to GXGX. This indicates lower risk in terms of short-term price fluctuations for CVII.Check GXGX's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HECCU trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HECCU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to HECCU's ROE of -0.10%. Regarding short-term risk, CVII is less volatile compared to HECCU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check HECCU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while ATMR trades at $10.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas ATMR's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to ATMR's ROE of +0.44%. Regarding short-term risk, CVII is less volatile compared to ATMR. This indicates lower risk in terms of short-term price fluctuations for CVII.Check ATMR's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SFTW trades at $11.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SFTW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SFTW's ROE of -0.56%. Regarding short-term risk, CVII is less volatile compared to SFTW. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SFTW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while ENFA trades at $9.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas ENFA's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to ENFA's ROE of -1.15%. Regarding short-term risk, CVII is less volatile compared to ENFA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check ENFA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while ENVI trades at $8.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas ENVI's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to ENVI. This indicates lower risk in terms of short-term price fluctuations for CVII.Check ENVI's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while ACTD trades at $7.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas ACTD's P/E ratio is -25.50. In terms of profitability, CVII's ROE is +0.02%, compared to ACTD's ROE of -0.00%. Regarding short-term risk, CVII is less volatile compared to ACTD. This indicates lower risk in terms of short-term price fluctuations for CVII.Check ACTD's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while VCKA trades at $9.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas VCKA's P/E ratio is 100.11. In terms of profitability, CVII's ROE is +0.02%, compared to VCKA's ROE of +1.68%. Regarding short-term risk, CVII is less volatile compared to VCKA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check VCKA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while THMA trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas THMA's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to THMA's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to THMA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check THMA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while LNFA trades at $10.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas LNFA's P/E ratio is 21.06. In terms of profitability, CVII's ROE is +0.02%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, CVII is less volatile compared to LNFA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check LNFA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FTIVU trades at $14.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FTIVU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FTIVU's ROE of -0.14%. Regarding short-term risk, CVII is less volatile compared to FTIVU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FTIVU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while STWO trades at $8.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas STWO's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to STWO's ROE of +4.68%. Regarding short-term risk, CVII is less volatile compared to STWO. This indicates lower risk in terms of short-term price fluctuations for CVII.Check STWO's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HYACU trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HYACU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to HYACU's ROE of -0.11%. Regarding short-term risk, CVII is more volatile compared to HYACU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check HYACU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FTIV trades at $13.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FTIV's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FTIV's ROE of -0.14%. Regarding short-term risk, CVII is less volatile compared to FTIV. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FTIV's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, BBCQW has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while BBCQW trades at $2.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas BBCQW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to BBCQW's ROE of N/A. Regarding short-term risk, CVII is less volatile compared to BBCQW. This indicates lower risk in terms of short-term price fluctuations for CVII.Check BBCQW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while AHAC trades at $10.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas AHAC's P/E ratio is -72.11. In terms of profitability, CVII's ROE is +0.02%, compared to AHAC's ROE of -16.18%. Regarding short-term risk, CVII is less volatile compared to AHAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check AHAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while AMHC trades at $10.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas AMHC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to AMHC's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to AMHC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check AMHC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HERA trades at $10.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HERA's P/E ratio is 46.32. In terms of profitability, CVII's ROE is +0.02%, compared to HERA's ROE of +0.01%. Regarding short-term risk, CVII is more volatile compared to HERA. This indicates higher risk in terms of short-term price fluctuations for CVII.Check HERA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HERAW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HERAW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, CVII is less volatile compared to HERAW. This indicates lower risk in terms of short-term price fluctuations for CVII.Check HERAW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FGNA trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FGNA's P/E ratio is -4.35. In terms of profitability, CVII's ROE is +0.02%, compared to FGNA's ROE of +0.46%. Regarding short-term risk, CVII is less volatile compared to FGNA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check FGNA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while DNAA trades at $14.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas DNAA's P/E ratio is -54.53. In terms of profitability, CVII's ROE is +0.02%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to DNAA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check DNAA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while RACA trades at $10.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas RACA's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to RACA's ROE of +0.00%. Regarding short-term risk, CVII is less volatile compared to RACA. This indicates lower risk in terms of short-term price fluctuations for CVII.Check RACA's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while TREB trades at $9.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas TREB's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to TREB's ROE of -12.26%. Regarding short-term risk, CVII is less volatile compared to TREB. This indicates lower risk in terms of short-term price fluctuations for CVII.Check TREB's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while PACE trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas PACE's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to PACE's ROE of -1.52%. Regarding short-term risk, CVII is less volatile compared to PACE. This indicates lower risk in terms of short-term price fluctuations for CVII.Check PACE's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while HERAU trades at $10.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas HERAU's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, CVII is more volatile compared to HERAU. This indicates higher risk in terms of short-term price fluctuations for CVII.Check HERAU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while LSAQ trades at $9.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas LSAQ's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to LSAQ's ROE of N/A. Regarding short-term risk, CVII is less volatile compared to LSAQ. This indicates lower risk in terms of short-term price fluctuations for CVII.Check LSAQ's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SRAC trades at $10.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SRAC's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SRAC's ROE of -0.90%. Regarding short-term risk, CVII is less volatile compared to SRAC. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SRAC's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while FTPAW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas FTPAW's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, CVII is more volatile compared to FTPAW. This indicates higher risk in terms of short-term price fluctuations for CVII.Check FTPAW's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, SBG has a market cap of 1B. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while SBG trades at $8.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas SBG's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to SBG's ROE of -0.86%. Regarding short-term risk, CVII is less volatile compared to SBG. This indicates lower risk in terms of short-term price fluctuations for CVII.Check SBG's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CVII-WT trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, CVII's ROE is +0.02%, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, CVII is more volatile compared to CVII-WT. This indicates higher risk in terms of short-term price fluctuations for CVII.Check CVII-WT's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CVII-UN has a market cap of 958.8M. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CVII-UN trades at $10.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, CVII's ROE is +0.02%, compared to CVII-UN's ROE of +0.02%. Regarding short-term risk, CVII is less volatile compared to CVII-UN. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CVII-UN's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, BRPM has a market cap of 944M. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while BRPM trades at $13.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas BRPM's P/E ratio is -72.74. In terms of profitability, CVII's ROE is +0.02%, compared to BRPM's ROE of +4.56%. Regarding short-term risk, CVII is less volatile compared to BRPM. This indicates lower risk in terms of short-term price fluctuations for CVII.Check BRPM's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, CRSAU has a market cap of 937.8M. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while CRSAU trades at $10.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas CRSAU's P/E ratio is -27.21. In terms of profitability, CVII's ROE is +0.02%, compared to CRSAU's ROE of -0.34%. Regarding short-term risk, CVII is less volatile compared to CRSAU. This indicates lower risk in terms of short-term price fluctuations for CVII.Check CRSAU's competition here

Churchill Capital Corp VII (NYSE: CVII) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVII stands at 914.7M. In comparison, BCTG has a market cap of 899.4M. Regarding current trading prices, CVII is priced at $9.99 on the NYSE, while BCTG trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVII currently has a P/E ratio of 999.00, whereas BCTG's P/E ratio is -204.00. In terms of profitability, CVII's ROE is +0.02%, compared to BCTG's ROE of -0.26%. Regarding short-term risk, CVII is less volatile compared to BCTG. This indicates lower risk in terms of short-term price fluctuations for CVII.Check BCTG's competition here